Target intelligence / Profile preview

Recombination Activating Gene 1

Molecular classification
Enzyme, Transcription factor
01

Overview

Recombination activating gene 1 (RAG1) encodes a protein essential for the development of adaptive immunity in vertebrates. RAG1, together with RAG2, forms the core of the V(D)J recombinase complex responsible for initiating somatic recombination of immunoglobulin and T cell receptor genes in developing B and T lymphocytes. Deficiency or mutations in RAG1 can cause severe combined immunodeficiency syndromes, including Omenn syndrome and SCID. Expression is tightly regulated and present only during specific windows of lymphocyte development.

Other names
RAG1
02

Mechanism of action

RAG1, along with RAG2, forms the V(D)J recombinase complex, which introduces double-strand breaks at recombination signal sequences (RSSs) flanking variable (V), diversity (D), and joining (J) gene segments to facilitate rearrangement by non-homologous end joining.

03

Biological functions

V(D)J recombinationAdaptive immunityDNA cleavageLymphocyte development
04

Disease associations

Severe combined immunodeficiency (SCID)Omenn syndromeCombined immunodeficiency with granuloma/autoimmunity (CID-G/A)Antibody deficiencyIdiopathic CD4+ T lymphopenia
05

Safety considerations

Mutations can lead to severe combined immunodeficiency syndromes.Loss of RAG1 function can result in the absence of mature B and T cells.

Beyond the preview

Go deeper on Recombination Activating Gene 1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Recombination Activating Gene 1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call